Perbedaan Indofarma Tbk. dan Rans Entertainmen Indonesia Tbk: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Rans Entertainmen Indonesia Tbk diperdagangkan di Rp200 (kapitalisasi pasar 2,57 T, volume 24 jam 67,92 jt). Perbedaan utamanya: Rans Entertainmen Indonesia Tbk jauh lebih besar — sekitar 6,6× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INAF | RANS | |
|---|---|---|
Kapitalisasi Pasar | 390,51 M | 2,57 T |
Volume | — | 67,92 jt |
Lot | — | 679,19 rb |
Perputaran | — | 13,51 M |
Harga Rata-rata | — | 198,89 |
Nilai Transaksi | — | 13,51 M |
Harga Ekuilibrium Indikatif | — | 200 |
Volume Ekuilibrium Indikatif | — | 4,66 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →PT. Rans Entertainmen Indonesia Tbk. (the Company) was established with Deed No. 04 on October 18, 2016, which was made before Raden Mas Dendy Subangil S.H., M.Kn., under the name of PT RNR Film Internasional. The Company started its commercial operations in 2018. The Company does not have a parent entity, the ultimate controlling party is Raffi Farid Ahmad as the Companys shareholder.
Selengkapnya di halaman RANS →